Watch Demo

Austria Antihypertensive Industry Outlook 2022 - 2026

See how Austria Antihypertensive performed compared to key markets such as Germany, Italy and Spain.

Key Market Indicators

Sales of antihypertensive medicines in Austria are projected to reach $59 million by 2026, a 0.5% year-on-year growth rate. Since 2015, the demand for these medicines in the country has risen 1.7% annually. Austria was in sixth place in 2021, slightly behind Canada's $58.52 million. Italy, Spain and Australia ranked second, third and fourth respectively.

Austria Antihypertensive Market Data and Forecasts

How much will Austria Antihypertensive Market grow to 2026?

Forecast: Antihypertensive Medicine Sales in Austria
Forecast: Renin-Angiotensin System Medicine Sales in Austria
Forecast: Antihypertensive Medicine Sales in Austria
Forecast: Antihypertensive Medicine Use in Austria
Forecast: Renin-Angiotensin System Medicine Sales in Austria
More in Antihypertensive Industry for 2027

Improve your Knowledge with the latest Indicators and Trends